| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Jul―04 |
Isolation of Bioactive Compounds in Allanblackia Floribunda Fruit and The Molecular Docking of The Compounds Against SARS-CoV-2 Variants |
Abimbola Olanipekun, Francis Jide Faleye, Ibiyinka Ogunlade, O. I. Akinwumi, T Esan |
| 2 |
[GO] |
2024―Feb―26 |
De novo Drug Design to Suppress Coronavirus RNA-Glycoprotein via PNA-Calcitonin |
Soykan AGAR, Barbaros AKKURT, Levent ALPARSLAN |
| 3 |
[GO] |
2024―Jan―30 |
Molecular Docking Interaction of Medicines Binding to COVID-19 Proteins |
Ammar IBRAHİM, Entesar SULLIMAN, Maher A IBRAHIM |
| 4 |
[GO] |
2021―Aug―15 |
Drug Repurposing Against SARS-CoV-2: Targeting NSP16-NSP10 Interaction |
Sefer BADAY |
| 5 |
[GO] |
2021―Jun―27 |
Drug Discovery and Treatment of an Emerging Pandemic Infection Covid-19 |
Arunesh MİSHRA, Pratibha MİSHRA, Ratnesh DAS |
| 6 |
[GO] |
2020―Okt―29 |
Chitosan-drug encapsulation as a potential candidate for COVID-19 drug delivery systems: A review |
Onome EJEROMEDOGHENE, Olayinka ODERİNDE, George EGEJURU, Sheriff ADEWUYİ |
| 7 |
[GO] |
2020―Jul―13 |
In silico, 6LU7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2 |
Mücahit ÖZDEMİR, Baybars KÖKSOY, Deniz CEYHAN, Mustafa BULUT, Bahattin YALCİN |
